BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 17011853)

  • 41. [Clinical observation of polypoidal choroidal vasculopathy].
    Zou WJ; Wen F; Wu ZF; Huang SZ; Zhang J; Luo GW
    Zhonghua Yan Ke Za Zhi; 2011 Jan; 47(1):39-44. PubMed ID: 21418926
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Indocyanine green angiography: guided photodynamic therapy for polypoidal choroidal vasculopathy.
    Otani A; Sasahara M; Yodoi Y; Aikawa H; Tamura H; Tsujikawa A; Yoshimura N
    Am J Ophthalmol; 2007 Jul; 144(1):7-14. PubMed ID: 17467649
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Idiopathic polypoidal choroidal vasculopathy: its extreme aspects in one patient--case report].
    Barreira IM; Aragão RE; Vale AB; Holanda Filha JG
    Arq Bras Oftalmol; 2005; 68(2):253-6. PubMed ID: 15905951
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tomographic features of branching vascular networks in polypoidal choroidal vasculopathy.
    Sato T; Kishi S; Watanabe G; Matsumoto H; Mukai R
    Retina; 2007 Jun; 27(5):589-94. PubMed ID: 17558321
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Idiopathic polypoidal choroidal vasculopathy.
    Cekić S; Risimić D; Jovanović I; Jocić JD
    Vojnosanit Pregl; 2012 Jan; 69(1):85-9. PubMed ID: 22397302
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Surgical outcomes of vitrectomy for breakthrough vitreous hemorrhage in eyes with exudative age-related macular degeneration.
    Iwase T; Baba T; Saito Y; Nizawa T; Yokouchi H; Kubota-Taniai M; Kitahashi M; Yamamoto S
    Int Ophthalmol; 2021 May; 41(5):1835-1844. PubMed ID: 33611763
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Retinal angiopathy and polypoidal choroidal vasculopathy.
    Iida T; Yannuzzi LA; Freund KB; Ciardella AP; Costa DL; Huang SJ; Golub BM
    Retina; 2002 Aug; 22(4):455-63. PubMed ID: 12172113
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improvement of angiographic findings of polypoidal choroidal vasculopathy after intravitreal injection of ranibizumab monthly for 3 months.
    Hikichi T; Ohtsuka H; Higuchi M; Matsushita T; Ariga H; Kosaka S; Matsushita R; Takami K
    Am J Ophthalmol; 2010 Nov; 150(5):674-682.e1. PubMed ID: 20691424
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of intravitreal bevacizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy.
    Gomi F; Sawa M; Wakabayashi T; Sasamoto Y; Suzuki M; Tsujikawa M
    Am J Ophthalmol; 2010 Jul; 150(1):48-54.e1. PubMed ID: 20609707
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recurrent bleeding after photodynamic therapy in polypoidal choroidal vasculopathy.
    Ojima Y; Tsujikawa A; Otani A; Hirami Y; Aikawa H; Yoshimura N
    Am J Ophthalmol; 2006 May; 141(5):958-60. PubMed ID: 16678520
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Polypoidal choroidal vasculopathy in exudative and haemorrhagic pigment epithelial detachments.
    Ahuja RM; Stanga PE; Vingerling JR; Reck AC; Bird AC
    Br J Ophthalmol; 2000 May; 84(5):479-84. PubMed ID: 10781511
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Idiopathic polypoidal choroidal vasculopathy: case report.
    Li CY; Chen YC; Ho CL; Ho JD; Chen SN
    Chang Gung Med J; 2001 Apr; 24(4):263-8. PubMed ID: 11413885
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Indentation of retinal pigment epithelium in polypoidal choroidal vasculopathy detected by retro-mode (scanning laser ophthalmoscopy)].
    Takeda M; Sato Y
    Nippon Ganka Gakkai Zasshi; 2012 Oct; 116(10):946-54. PubMed ID: 23285842
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Idiopathic polypoidal choroidal vasculopathy masquerading as choroidal tumors: one year follow-up of a peripheral lesion.
    Preti RC; Monteiro ML; Morita C; Helal Junior J; Zacharias LC; Ferraz DA; Pelayes DE; Takahashi WY
    Arq Bras Oftalmol; 2015; 78(3):187-9. PubMed ID: 26222111
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Polypoidal choroidal vasculopathy.
    Ciardella AP; Donsoff IM; Huang SJ; Costa DL; Yannuzzi LA
    Surv Ophthalmol; 2004; 49(1):25-37. PubMed ID: 14711438
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polypoidal choroidal vasculopathy masquerading as neovascular age-related macular degeneration refractory to ranibizumab.
    Stangos AN; Gandhi JS; Nair-Sahni J; Heimann H; Pournaras CJ; Harding SP
    Am J Ophthalmol; 2010 Nov; 150(5):666-73. PubMed ID: 20719300
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics.
    Sho K; Takahashi K; Yamada H; Wada M; Nagai Y; Otsuji T; Nishikawa M; Mitsuma Y; Yamazaki Y; Matsumura M; Uyama M
    Arch Ophthalmol; 2003 Oct; 121(10):1392-6. PubMed ID: 14557174
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Optical coherence tomographic findings of idiopathic polypoidal choroidal vasculopathy.
    Otsuji T; Takahashi K; Fukushima I; Uyama M
    Ophthalmic Surg Lasers; 2000; 31(3):210-4. PubMed ID: 10847497
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison between clinical and ultrasound findings in patients with vitreous hemorrhage.
    Rabinowitz R; Yagev R; Shoham A; Lifshitz T
    Eye (Lond); 2004 Mar; 18(3):253-6. PubMed ID: 15004573
    [TBL] [Abstract][Full Text] [Related]  

  • 60. One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients.
    Gomi F; Ohji M; Sayanagi K; Sawa M; Sakaguchi H; Oshima Y; Ikuno Y; Tano Y
    Ophthalmology; 2008 Jan; 115(1):141-6. PubMed ID: 17582498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.